| Patient | Jean-Jacques Rousseau |
|---|---|
| Date of birth | 1712-06-28 |
| Identifiers | MRN HR-EN003-SYN-TD; SSN (made up) 000-03-2716 |
| Document date | 1767-04-21 |
| Author | Celestine Marchetti-Owusu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Review four weeks after urethroplasty; wants to try the medicine for sleep and worry. [S]
Mr. Rousseau returns four weeks after an excision and primary anastomosis bulbar urethroplasty. The pathology showed dense fibrosis of the corpus spongiosum without inflammation or malignancy. The catheter came out a week ago after a urethrogram around it showed no leak. He now passes urine with what he calls a stream he has not had since childhood, empties fully, and gets up once at night. The perineal wound is healed; he takes acetaminophen once a day at most. He has had seven sessions of CBT for psychosis. He says the beliefs still weigh on him at night and he sleeps about five hours, and that, now his bladder no longer wakes him, he wants to see whether the medicine he was offered helps his sleep and worry. He has had no thoughts of suicide or of harming anyone. [S]
| Element | Detail |
|---|---|
| Surgery | Anastomotic bulbar urethroplasty four weeks ago; catheter out a week ago with no leak |
| Voiding | Free stream; up once at night |
| Psychotherapy | Seven CBT sessions |
| Medication decision | Asks to start aripiprazole |
| Safety | No thoughts of suicide or of harming anyone |
| System | Result | Finding |
|---|---|---|
| Genitourinary | Negative | Strong stream, empties fully, no burning, no blood; erections unchanged |
| Integumentary | Negative | Perineal wound healed |
| Neurological | Negative | No tremor, stiffness, restlessness, or abnormal movements |
| Psychiatric | Positive | Persecutory beliefs and night-time worry; no hallucinations; no thoughts of suicide or of harming anyone |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for pain, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 1767-03-24 | active | S |
| Aripiprazole 5 mg oral tablet, one tablet by mouth each morning | One tablet each morning | Oral route | 1767-04-21 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1767-04-21 | Body height | 166 | cm | S |
| 1767-04-21 | Body weight | 63.2 | kg | S |
| 1767-04-21 | Body mass index (BMI) [Ratio] | 22.9 | kg/m2 | S |
| 1767-04-21 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1767-04-21 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1767-04-21 | Heart rate | 74 | /min | S |
| 1767-04-21 | Respiratory rate | 14 | /min | S |
| 1767-04-21 | Body temperature | 36.7 | Cel | S |
| 1767-04-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1767-04-21 | Symptom score [AUASI] | 6 | {score} | S | ||
| 1767-04-21 | If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] | 2 | {score} | S | ||
| 1767-04-21 | Maximum Urine flow by Uroflowmetry | 21.5 | mL/s | A maximum flow of 15 mL/s or more is normal for a voided volume above 150 mL | Normal | S |
| 1767-04-21 | US Urinary bladder Volume post void | 25 | mL | <=100 mL | Normal | S |
| 1767-04-21 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | {score} | S | ||
| 1767-04-21 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1767-04-21 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1762)/1.73 sq M | 92 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1767-04-21 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 1767-04-21 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| 1767-04-21 | Cholesterol [Mass/volume] in Serum or Plasma | 196 | mg/dL | <=199 mg/dL | Normal | S |
| 1767-04-21 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 48 | mg/dL | >=40 mg/dL | Normal | S |
| 1767-04-21 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 122 | mg/dL | <=129 mg/dL | Normal | S |
| 1767-04-21 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 1767-04-21 | Waist Circumference at umbilicus by Tape measure | 92 | cm | Below 102 cm for men | Normal | S |
Vital signs recorded on 1767-04-21; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well and cheerful about his bladder |
| Genitourinary | Perineal incision healed; no swelling or tenderness; right inguinal hernia small and reducible |
| Neurological | No tremor, rigidity, or involuntary movements; AIMS total 0 at baseline |
| Mental status | Calm and courteous; mood "better by day, troubled at night"; persecutory beliefs unchanged in content; no hallucinations; no suicidal or violent ideation; capacity for the medication decision present |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fixed beliefs that former friends and colleagues are plotting to ruin him, with poor sleep, present for years and worse over the past year; cause not yet established; psychiatric and medical assessment under way | resolved | confirmed | R46.5 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the psychiatry consultation; his documented beliefs of 1766 are echoed. |
| Weak urinary stream, straining, incomplete emptying (post-void residual 180 mL), and painful urination since childhood, treated for years by self-dilation with urethral sounds; cause not yet established; urethral imaging and endoscopy booked | resolved | confirmed | R33.9 | S — Synthetic presenting concern at the index visit, superseded by the urethrogram and cystoscopy diagnosis; his documented lifelong retention and self-treatment with bougies are echoed. |
| Delusional disorder, persecutory type (DSM-5-TR), of about nine years' duration, with non-bizarre beliefs of a coordinated campaign against him; no hallucinations, disorganization, or mood episode; normal cognition; insomnia secondary to preoccupation; synthetic modern counterpart of his documented persecutory beliefs | active | confirmed | F22 | S — Synthetic modern diagnosis. His beliefs and conduct are documented (D); calling them a paranoid delusion is a retrospective interpretation (R), made difficult by the real persecution he suffered. |
| Bulbar urethral stricture, 1.5 cm, dense and ring-like (lumen about 8 French), idiopathic and probably congenital in origin, with decades of self-dilation; bladder trabeculation without hydronephrosis; kidney function normal; synthetic modern counterpart of his documented lifelong urinary retention | active | confirmed | N35.812 | S — Synthetic modern diagnosis. His lifelong retention is documented (D); its cause is disputed (R), and the autopsy found no urethral lesion (D), so this stricture is not presented as his historical diagnosis. |
| Right inguinal hernia, reducible and minimally symptomatic, likely aggravated by years of straining to pass urine | active | confirmed | K40.90 | S — Synthetic finding on examination; it echoes the documented rupture of 1758, whose site the source does not state. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Suicide and violence risk review (C-SSRS Since Last Visit, PHQ-9 item 9, thoughts of harming others, plans to confront anyone, access to weapons) and the safety plan | Every visit | Completed today | No thoughts of suicide or of harming anyone; no plan to confront anyone; no weapons; PHQ-9 item 9 scored 0; safety plan reviewed |
| Survey | PHQ-9 for depressive symptoms | At least monthly | Completed today | 6; the psychologist recorded 6 and 7 at sessions in March and April |
| Referral | Cognitive behavioral therapy for psychosis | About 16 sessions | Completed today | Seven sessions; continuing |
| Medication safety | Antipsychotic started by shared decision-making | When the patient chooses it | Completed today | Aripiprazole 5 mg started at his request after benefits and risks were discussed |
| Laboratory | Baseline fasting glucose, hemoglobin A1c, and lipids before a second-generation antipsychotic | Baseline, 12 weeks, then yearly | Completed today | Glucose 92 mg/dL, A1c 5.4 percent, total cholesterol 196, HDL 48, LDL 122, triglycerides 130 mg/dL |
| Examination | Baseline weight, BMI, waist, and blood pressure | Weight at baseline, 4, 8, and 12 weeks; waist and blood pressure at baseline and 12 weeks | Completed today | 63.2 kg, BMI 22.9, waist 92 cm, 124/78 mmHg |
| Examination | AIMS and akathisia check | AIMS at baseline and every 6 months; akathisia at each visit | Completed today | AIMS 0; no restlessness |
| Survey | IPSS and quality-of-life score after treatment | After treatment and at each surveillance visit | Completed today | IPSS 6; quality of life 2 |
| Imaging | Uroflowmetry and post-void residual after urethroplasty | After catheter removal, then at about 3, 6, and 12 months | Completed today | Maximum flow 21.5 mL/s; residual 25 mL |
| Imaging | Pericatheter urethrogram before catheter removal | About three weeks after anastomotic urethroplasty | Up to date | A week ago: no leak; catheter removed |
| Laboratory | Creatinine and eGFR | After relief of obstruction, and before metformin, NSAIDs, or contrast | Completed today | 0.98 mg/dL; eGFR 92 |
| Examination | Inguinal hernia check | At each review while under watchful waiting | Completed today | Unchanged |
Goal progress:
Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition. Am J Psychiatry 2020;177(9):868-872 (2020); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (PHQ-9, suicide-risk review, and second-generation antipsychotic monitoring) (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Urethral Stricture Disease: AUA Guideline Amendment (2023). Wessells H, et al. J Urol 2023;210(1):64-71. PMID 37096574 (2023); International guidelines for groin hernia management. HerniaSurge Group. Hernia 2018;22(1):1-165 (2018)
Follow-up: Weight check in four weeks; review at twelve weeks on aripiprazole with fasting blood tests and a flow test; CBT continues. Next scheduled visit 1767-07-14: twelve-week aripiprazole and urethroplasty follow-up. [S]